Literature DB >> 24895223

Impact of adolescent GluA1 AMPA receptor ablation in forebrain excitatory neurons on behavioural correlates of mood disorders.

Miriam A Vogt1, Hasan Elkin, Natascha Pfeiffer, Rolf Sprengel, Peter Gass, Dragos Inta.   

Abstract

Glutamatergic dysfunctions have recently been postulated to play a considerable role in mood disorders. However, molecular mechanisms underlying these effects have been poorly deciphered. Previous work demonstrated the contribution of GluA1-containing AMPA receptors (AMPAR) to a depression-like and anxiety-like phenotype. Here we investigated the effect of temporally and spatially restricted gene manipulation of GluA1 on behavioural correlates of mood disorders in mice. Here we show that tamoxifen-induced GluA1 deletion restricted to forebrain glutamatergic neurons of post-adolescent mice does not induce depression- and anxiety-like changes. This differs from the phenotype of mice with global AMPAR deletion suggesting that for mood regulation AMPAR may be particularly important on inhibitory interneurons or already early in development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24895223     DOI: 10.1007/s00406-014-0509-5

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  29 in total

Review 1.  Dynamic aspects of CNS synapse formation.

Authors:  A Kimberley McAllister
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

2.  Differential c-Fos induction by different NMDA receptor antagonists with antidepressant efficacy: potential clinical implications.

Authors:  Dragos Inta; Massimo Trusel; Marco A Riva; Rolf Sprengel; Peter Gass
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-29       Impact factor: 5.176

Review 3.  Genetic dissection of neural circuits and behavior in Mus musculus.

Authors:  Robbert Havekes; Ted Abel
Journal:  Adv Genet       Date:  2009       Impact factor: 1.944

4.  The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug.

Authors:  Dragos Inta; Dragana Filipovic; Juan M Lima-Ojeda; Christof Dormann; Natascha Pfeiffer; Fabrizio Gasparini; Peter Gass
Journal:  Neuropharmacology       Date:  2012-01-12       Impact factor: 5.250

5.  Learned helplessness: validity and reliability of depressive-like states in mice.

Authors:  S Chourbaji; C Zacher; C Sanchis-Segura; C Dormann; B Vollmayr; P Gass
Journal:  Brain Res Brain Res Protoc       Date:  2005-11-23

6.  The suitability of 129SvEv mice for studying depressive-like behaviour: both males and females develop learned helplessness.

Authors:  Sabine Chourbaji; Natascha Pfeiffer; Christof Dormann; Christiane Brandwein; Rosa Fradley; Malcolm Sheardown; P Gass
Journal:  Behav Brain Res       Date:  2010-03-15       Impact factor: 3.332

Review 7.  Evidence for GABAergic inhibitory deficits in major depressive disorder.

Authors:  Paul E Croarkin; Andrea J Levinson; Zafiris J Daskalakis
Journal:  Neurosci Biobehav Rev       Date:  2010-10-12       Impact factor: 8.989

8.  Deletion of running-induced hippocampal neurogenesis by irradiation prevents development of an anxious phenotype in mice.

Authors:  Johannes Fuss; Nada M B Ben Abdallah; Frank W Hensley; Klaus-Josef Weber; Rainer Hellweg; Peter Gass
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

9.  Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.

Authors:  E Engin; D Treit; C T Dickson
Journal:  Neuroscience       Date:  2009-03-24       Impact factor: 3.590

10.  Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain.

Authors:  Juan M Lima-Ojeda; Miriam A Vogt; Natascha Pfeiffer; Christof Dormann; Georg Köhr; Rolf Sprengel; Peter Gass; Dragos Inta
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-04-30       Impact factor: 5.067

View more
  7 in total

1.  Suicide ideation, stability of symptoms and effects of aerobic exercise in major depression.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-10       Impact factor: 5.270

Review 2.  Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population.

Authors:  Charlene Faye; Josephine C Mcgowan; Christine A Denny; Denis J David
Journal:  Curr Neuropharmacol       Date:  2018-03-05       Impact factor: 7.363

3.  Adult AMPA GLUA1 receptor subunit loss in 5-HT neurons results in a specific anxiety-phenotype with evidence for dysregulation of 5-HT neuronal activity.

Authors:  Tillmann Weber; Miriam A Vogt; Sarah E Gartside; Stefan M Berger; Rafael Lujan; Thorsten Lau; Elke Herrmann; Rolf Sprengel; Dusan Bartsch; Peter Gass
Journal:  Neuropsychopharmacology       Date:  2014-12-30       Impact factor: 7.853

4.  Phenotyping Young GluA1 Deficient Mice - A Behavioral Characterization in a Genetic Loss-of-Function Model.

Authors:  Maria Reiber; Helen Stirling; Rolf Sprengel; Peter Gass; Rupert Palme; Heidrun Potschka
Journal:  Front Behav Neurosci       Date:  2022-06-02       Impact factor: 3.617

5.  Gene deficiency and pharmacological inhibition of caspase-1 confers resilience to chronic social defeat stress via regulating the stability of surface AMPARs.

Authors:  M-X Li; H-L Zheng; Y Luo; J-G He; W Wang; J Han; L Zhang; X Wang; L Ni; H-Y Zhou; Z-L Hu; P-F Wu; Y Jin; L-H Long; H Zhang; G Hu; J-G Chen; F Wang
Journal:  Mol Psychiatry       Date:  2017-04-18       Impact factor: 15.992

Review 6.  Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13).

Authors:  Andrei-Nicolae Vasilescu; Nina Schweinfurth; Stefan Borgwardt; Peter Gass; Undine E Lang; Dragos Inta; Sarah Eckart
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-31       Impact factor: 2.570

Review 7.  Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions.

Authors:  Carmine Tomasetti; Felice Iasevoli; Elisabetta Filomena Buonaguro; Domenico De Berardis; Michele Fornaro; Annastasia Lucia Carmela Fiengo; Giovanni Martinotti; Laura Orsolini; Alessandro Valchera; Massimo Di Giannantonio; Andrea de Bartolomeis
Journal:  Int J Mol Sci       Date:  2017-01-12       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.